Harvard University/MGH — Boston, Massachusetts

Harvard University/MGH is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Harvard University/MGH has participated in 1 clinical trials.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Sponsors: Biogen.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harvard University/MGH?

Harvard University/MGH has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harvard University/MGH conducted?

Harvard University/MGH has 1 clinical trials on record. Their work covers Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Is Harvard University/MGH accredited by Crixeo Health?

Harvard University/MGH has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harvard University/MGH?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.